Search results
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 7 days agoClinic. Drugs including Regeneron Pharmaceuticals’ Eylea, which had $5.9 billion in sales last year,...
Merck introduces sterility testing solution for pharma quality control
Pharmaceutical Technology via Yahoo Finance· 7 days agoMerck KGaA, based in Darmstadt, Germany, has introduced the M-Trace Software & Mobile App, designed...
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Zacks via Yahoo Finance· 2 days agoPharmaceutical Intellidex Index is comprised of stocks of U.S. pharmaceutical companies. It is...
Merck eyes purchase of ophthalmology company
WFMZ Eastern Pennsylvania and Western New Jersey· 6 days agoTake Merck, for example. Its blockbuster cancer drug, Keytruda, is now the largest selling drug in the world. In the past few weeks, studies have shown...
Merck to Acquire EyeBio
Morningstar· 7 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today ...
Merck & Co. sees clear vision to new ophthalmology assets with $3B EyeBio buy
FierceBiotech· 7 days agoMerck & Co. is focusing in on eye diseases with the $3 billion acquisition of ophthalmology-focused Eyebiotech. Merck will take on a pipeline of vision ...
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
Zacks via Yahoo Finance· 5 days agoJ&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority...
Health Care Roundup: Market Talk
The Wall Street Journal· 5 days agoThe laboratory-supplies company says it now expects a bigger than expected drop in its end-markets, especially in the pharmaceutical industry, which it...
Pharma stock jumps 3% after company announced to expand its manufacturing facilities
Investing.com· 2 days agoOn Monday, the share price of one of the world’s top 5 manufacturers of semi-synthetic penicillins...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 1 day agoThe new proprietary cell line development platform combines a robust cell line, transposon technology with high throughput clone screening and single cell imaging to deliver highly efficient ...
